Viewing StudyNCT00003959

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 10:17 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00003959
Status: COMPLETED
Last Update Posted: 2013-01-16
First Post: 1999-11-01
Brief Title: Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndromes
Leukemia
Keywords:
Name View
secondary myelodysplastic syndromes View
refractory anemia View
refractory anemia with ringed sideroblasts View
refractory anemia with excess blasts View
chronic myelomonocytic leukemia View
de novo myelodysplastic syndromes View
previously treated myelodysplastic syndromes View